Bausch & Lomb (BLCO) Other financing activities (2023 - 2026)

Bausch & Lomb (BLCO) posted Other financing activities of $2.0 million for Q1 2026, up 200.0% on a QoQ basis from -$2.0 million in Q4 2023.

Bausch & Lomb (BLCO) Other financing activities (2023 - 2026) Analysis & Trends

Bausch & Lomb's Other financing activities history runs 2 years deep, the most recent figure standing at $2.0 million for Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (changed N/A YoY) and the FY2024 annual result came in at -$1.0 million, up 50.0% from the prior year.
Other financing activities was $2.0 million for Q1 2026 at Bausch & Lomb, up from -$2.0 million in the prior quarter.
Across five years, Other financing activities topped out at $2.0 million in Q1 2026 and bottomed at -$2.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Bausch & Lomb	5.68 Bn	5.47 Bn	973.00 Mn

Download Data